Capricorn Partners is an independent manager of private and quoted equity funds that invest in minority shareholding positions of innovative companies with technology as competitive advantage.
Through our private venture capital funds, we invest in promising companies with technological advantages in sustainable chemistry, cleantech, health-tech, digital technologies and artificial intelligence. We are convinced that by investing in new technologies and innovations we can make a positive impact on our society and contribute to a better and more sustainable world, whilst achieving an acceptable return.
We support the growth of our portfolio companies as active value adding shareholders towards successful businesses and profitable exits.
Through our Quest Funds, we invest in best-of-class quoted and unquoted companies, managed by our dedicated team of specialists, focused on financial strength, growth prospects, market position, management strength and valuation.
Helsinki, Finland: 13 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the…
Helsinki, Finland: 22 December 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received three new NBS system orders in December. One purchase order came from a new neurosurgical customer in Spain. Two other…
Amsterdam, the Netherlands and Leuven, Belgium: 1 December 2020 – EclecticIQ, a global threat intelligence, hunting and response technology provider, has raised € 20 million in Series‑C financing, led by Ace Management, Europe’s leading cyber growth…